CClinicalTrials.gg
Status unknownNCT00173121Updated Sep 15, 2005

Environmental Enterovirus Monitoring

An observational study in Transmission Condition, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 1 Week to 18 Years. Per ClinicalTrials.gov, last updated 2005-09-15.

Sponsored by National Taiwan University Hospital · Observational

The sponsor has not verified this record recently (last verified Apr 2005), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Time perspective
Other
Enrollment
50
Ages
1 Week to 18 Years
Sex
All
01

Study summary

From last decades, because of lacking the powerful quantitative methods, such as real-time qPCR, there is no environmental monitoring data about enterovirus transmission. If the major transmission routes and risk factor are still not clear, it will be very hard for making the prevention and control strategies. Today, the most popular prevention suggestion for children is keeping them away from crowded public places during the peak contagious season, because enteroviruses are easily transmitted through aerosols over a distance of meters, and even between separated rooms (Chang et al., 2004). However, adults may as easily be infected, but don』t have any disease symptoms or carry the virus home. Another recommendation is washing hands to avoid contact of hands or anything else with the mouth and nose, as it is through contact of viruses with the mucosal membranes in the mouth and nasal passages that infection occurs. However, these actions did not be great helpful for preventing enterovirus infection and spread. Understanding and disrupting the major transmission pass way of enterovirus could be more effective than just keeping personal hygiene. Therefore, an applicable environmental monitoring program is needed for understanding the transmission routes and risk factor of enterovirus infection. In this study, we will monitor enteroviruses in hospital, household and kindergarten. For the environmental monitoring of enteroviruses, we will apply traditional plaque assay, real-time quantitative PCR and combine with questionnaire-based interviews to understand the infectious types and concentration of enterovirus from indoor air, surface and water for recognizing the transmission routes of enterovirus and the relationships between virus concentration and the symptoms of the cases.

Read the detailed description

Environmental Monitoring Program for Enterovirus (1) Case Collection. The studies cases include patients who were suspected of having enterovirus illnesses, such as HFMD and herpangina. Institutional review board approval was obtained from the Hospital for this study and informed consent was obtained from all patients or their parents. (2) Questionnaire. questionnaire based interviews were used to collect information about the family members, including demographic data, the number of bedrooms in the house, amount of contact time with the patient, presence and pattern of current or recent signs and symptoms. (3) Patient and culture samples. Laboratory evidence of enterovirus infection was defined as the isolation of enterovirus from a throat , and rectal swab sample. (4) Environmental Sampling. (a) Air sampling. For the filter/real-time qPCR assay, the air in each ward was filtered through a 37-mm-diameter Nuclepore filter (Costar, Cambridge, MA), which is a track-etched polycarbonate filter consisting of a polycarbonate membrane with straight-through pores of uniform size (0.4 μm). The filters were supported by cellulose pads and loaded into open-face three-piece plastic cassettes. The pump and filter apparatus were placed within 1 m from the patient's bed on an adjacent nightstand. (b) Surface sampling Regarding surface sampling, surfaces of environment and equipment were sampled with moistened sterile cotton swabs.

02

Conditions studied

  • Transmission Condition

Browse trials for

Keywords

  • enterovirus, environment, aerosol, air
03

In context

Enterovirus Infections

47 studies on the registry are indexed under Enterovirus Infections; 5 are open to participants now.

This study's enrollment of 50 is below the median of 214 across 14 observational studies indexed under Enterovirus Infections.

Browse Enterovirus Infections studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Week to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • any case of enterovirus infection

Exclusion criteria

Exclusion Criteria:

  • not enterovirus infection cases
05

Study design

Time perspective
Other
Enrollment
50 participants
06

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hsopital
    Taipei, 100, Taiwan
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2005, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00173121
Lead sponsor
National Taiwan University Hospital
First posted
Sep 15, 2005
Start date
May 2005
Completion
Jun 2005
Last update
Sep 15, 2005

Study contacts

Luan-Yin Chang, MD
Contact
ly7077@tpts6.seed.net.tw
886-2-23123456 ext. 3245
Luan-Yin Chang Chang, MD, PhD
principal investigator · National Taiwan University Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion